Metric Finance
LearnFAQ
LearnFAQ

Learn / CORT

NASDAQ: CORT

Corcept Therapeutics (CORT) stock, explained like you're 5

Corcept Therapeutics trades on the Nasdaq under the ticker CORT. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 13.1 billion dollars.

Ticker
CORT
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Large cap, about 13.1 billion dollars

Is Corcept Therapeutics a small, medium or large cap company?

Yes. Corcept Therapeutics is a large cap stock. Its market cap, which is the total value of all its shares, is about 13.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Corcept Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves CORT stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Corcept Therapeutics (CORT) Stock Looks Fully Priced For Its Sales Story (Yahoo Finance)
  • A director's trust sells 10,000 shares under a trading plan at Corcept Therapeutics (CORT). (Stock Titan)
  • Eight firms give Corcept Therapeutics stock a USD 138.17 target (ad-hoc-news.de)
  • Corcept Therapeutics (NasdaqCM:CORT) Stock Forecast & Analyst Predictions (Simply Wall Street)
  • Are Options Traders Betting on a Big Move in Corcept Therapeutics Stock? (TradingView)

Follow CORT in your daily brief

Each trading day at 5 PM ET we post what happened to Corcept Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow CORT

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Corcept Therapeutics stock

What does Corcept Therapeutics do?

Corcept Therapeutics trades on the Nasdaq under the ticker CORT. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 13.1 billion dollars.

What is the ticker symbol for Corcept Therapeutics?

Corcept Therapeutics trades under the ticker CORT on the Nasdaq.

What is Corcept Therapeutics's market cap?

Corcept Therapeutics is a large cap stock with a market cap of about 13.1 billion dollars.

How does Corcept Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves CORT stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow CORT stock every day?

Add CORT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow CORT daily

A free brief on Corcept Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare CORT: CORT vs NVS, CORT vs AZN, CORT vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed